These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis. Konno K, Oizumi K, Yamada S, Ogata K, Sato M. Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624 [No Abstract] [Full Text] [Related]
15. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3. Oka S, Sasaki M, Kobayashi T, Matsuda T. Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627 [No Abstract] [Full Text] [Related]
16. Rifampicin in the treatment of previously untreated pulmonary tuberculosis. Orlowski EH. Respiration; 1971 Sep; 28():Suppl:100-6. PubMed ID: 5004830 [No Abstract] [Full Text] [Related]
17. Rifampin. Schonell M, Dorken E, Grzybowski S. Can Med Assoc J; 1972 Apr 08; 106(7):783-6. PubMed ID: 4622757 [Abstract] [Full Text] [Related]
18. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. VII. September 1965 to September 1969. Hobby GL, Johnson PM, Boytar-Papirnyik V. Am Rev Respir Dis; 1970 Sep 08; 102(3):347-55. PubMed ID: 4989604 [No Abstract] [Full Text] [Related]
19. Short-course treatment regimens for patients with tuberculosis. Dutt AK, Stead WW. Arch Intern Med; 1980 Jun 08; 140(6):827-9. PubMed ID: 6770770 [No Abstract] [Full Text] [Related]